NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 237 filers reported holding NOVOCURE LTD in Q1 2024. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,951,950 | +9.6% | 1,515,000 | 0.0% | 11.32% | +23.0% |
| Q1 2024 | $23,679,450 | +4.7% | 1,515,000 | 0.0% | 9.20% | +54.2% |
| Q4 2023 | $22,618,950 | -7.6% | 1,515,000 | 0.0% | 5.97% | +23.1% |
| Q3 2023 | $24,467,250 | -61.1% | 1,515,000 | 0.0% | 4.85% | -55.0% |
| Q2 2023 | $62,872,500 | -31.0% | 1,515,000 | 0.0% | 10.78% | -27.4% |
| Q1 2023 | $91,112,100 | -18.0% | 1,515,000 | 0.0% | 14.85% | +7.1% |
| Q4 2022 | $111,125,249 | – | 1,515,000 | – | 13.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |